Alain Morvan - Coloplast VP Europe
| COLO-B Stock | DKK 889.40 2.40 0.27% |
Insider
Alain Morvan is VP Europe of Coloplast AS
| Phone | 45 49 11 11 11 |
| Web | https://www.coloplast.com |
Coloplast Management Efficiency
The company has return on total asset (ROA) of 0.1714 % which means that it generated a profit of $0.1714 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7507 %, meaning that it generated $0.7507 on every $100 dollars invested by stockholders. Coloplast's management efficiency ratios could be used to measure how well Coloplast manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Gunther Pausch | GN Store Nord | N/A | |
| Thomas Henriksen | Ambu AS | 50 | |
| Jorgen Moeller | DSV Panalpina AS | 70 | |
| Ehtisham Rabbani | GN Store Nord | N/A | |
| Mns Barsne | Ambu AS | N/A | |
| Steven Block | Ambu AS | 60 | |
| Lars AndersenLange | GN Store Nord | N/A | |
| Anne Veyhe | GN Store Nord | N/A | |
| Steen Laursen | GN Store Nord | N/A | |
| Anders Williamsson | Ambu AS | 69 | |
| Mikkel Wagner | Ambu AS | N/A | |
| Henrik Ankjr | Ambu AS | N/A | |
| Michael Ebbe | DSV Panalpina AS | 53 | |
| Brian Pedersen | GN Store Nord | N/A | |
| Bassel Rifai | Ambu AS | N/A | |
| Aurangzeb Khan | GN Store Nord | N/A | |
| Niels Smedegaard | DSV Panalpina AS | 57 | |
| MarieLouise Aamund | DSV Panalpina AS | 51 | |
| Britt Jensen | Ambu AS | 50 | |
| Thomas Schmidt | Ambu AS | 52 | |
| Nicolai Thomsen | Ambu AS | N/A | |
Management Performance
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 |
Coloplast AS Leadership Team
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert, VP Relations | ||
| Allan Rasmussen, Ex Operations | ||
| Alain Morvan, VP Europe | ||
| Nicolai Andersen, Ex Innovation | ||
| Thomas Barfod, Controller Director | ||
| Anders LonningSkovgaard, Ex CFO | ||
| Kristian Villumsen, Pres CEO | ||
| Paul Marcun, Ex Growth | ||
| Dennis Kaysen, Director Communications | ||
| Dorthe Ronnau, VP Culture |
Coloplast Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Coloplast a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 203.46 B | |||
| Shares Outstanding | 194.31 M | |||
| Shares Owned By Insiders | 35.00 % | |||
| Shares Owned By Institutions | 25.53 % | |||
| Price To Earning | 42.10 X | |||
| Price To Book | 22.36 X |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.